Soligenix   Report issue

For profit Phase 2 Phase 3
Founded: Princeton NJ United States (1987)

Organization Overview

First Clinical Trial
2009
NCT00926575
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Soligenix